Home
Jon Arne Søreide's picture

Jon Arne Søreide

Professor
  • E-mailJonArne.Soreide@uib.no
  • Phone+47 51 51 83 37+47 905 31 770
  • Visitor Address
    Stavanger University Hospital
    Dept. of GI-Surgery
    4068 Stavanger
  • Postal Address
    Postboks 7804
    5020 Bergen
  • 2020. Post hepatectomy liver failure (PHLF) – Recent advances in prevention and clinical management. 1-9.
  • 2020. Percutaneous cholecystostomy – An option in selected patients with acute cholecystitis. Medicine. 1-6.
  • 2020. Early diagnosis is associated with improved clinical outcomes in benign esophageal perforation: an individual patient data meta-analysis. Surgical Endoscopy. 14 pages.
  • 2020. Centralizing a national pancreatoduodenectomy service: striking the right balance. BJS Open. 904-913.
  • 2020. A plasma protein biomarker strategy for detection of small intestinal neuroendocrine tumors. Neuroendocrinology.
  • 2019. The gastrinoma saga before Zollinger and Ellison: The Strøm case revisited. Annals of Surgery. e19-e21.
  • 2019. Roar Strøm - kirurgen som kom Zollinger og Ellison i forkjøpet. Tidsskrift for Den norske legeforening.
  • 2019. Pooled analysis of WHO Surgical Safety Checklist use and mortality after emergency laparotomy. British Journal of Surgery. 103-112.
  • 2019. Palliative surgical outcome score (PSOS) in patients treated palliatively with self-expanding metal stent (SEMS) for malignant incurable colorectal obstruction. Surgial oncology. 134-139.
  • 2019. Non-curative treatment of patients with colorectal cancer – a national cohort study.
  • 2019. Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation. British Journal of Surgery. 756-764.
  • 2019. Kirurgisk verdensnyhet fra Stavanger. Stavanger Aftenblad.
  • 2019. Global variation in anastomosis and end colostomy formation following left-sided colorectal resection. BJS Open. 403-414.
  • 2019. Endoscopic retrograde cholangiopancreatography (ERCP): lessons learned from population-based national registries: a systematic review. 1731-1748.
  • 2019. Elevated Microsatellite Alterations at Selected Tetranucleotides (EMAST) in Colorectal Cancer is Associated with an Elderly, Frail Phenotype and Improved Recurrence-Free Survival. Annals of Surgical Oncology.
  • 2018. The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantification in Stage I to III Colon Cancer. Translational Oncology. 436-443.
  • 2017. Trump's ban on colleagues from Islamic countries. The Lancet. 804-804.
  • 2017. The Prognostic Relevance of Sentinel Lymph Node Metastases Assessed by PHGR1 mRNA Quantitation in Stage I-III Colon Cancer.
  • 2017. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) – study protocol for a national multicentre randomized controlled trial. BMC Surgery.
  • 2017. Mennesker vi møter. Tidsskrift for Den norske legeforening. 779-779.
  • 2017. Intramural gastric pseudocyst: A case report and a comprehensive literature review. 1-5.
  • 2017. Compensation claims for sub-substandard care of patients with gastroentero-pancreatic neuroendocrine tumors: A nationwide descriptive study of cases between 2005-2016 in norway. Anticancer Research. 5667-5671.
  • 2016. Primary Leiomyosarcoma of the Pancreas—a Case Report and a Comprehensive Review. Journal of Gastrointestinal Cancer. 8 pages.
  • 2016. Nationwide implementation of laparoscopic surgery for colon cancer: short-term outcomes and long-term survival in a population-based cohort. Surgical Endoscopy. 12 pages.
  • 2016. Long-term mortality in patients operated for perforated peptic ulcer: factors limiting longevity are dominated by older age, comorbidity burden and severe postoperative complications. World Journal of Surgery. 410-418.
  • 2016. Improving pancreas surgery over time: Performance factors related to transition of care and patient volume. International Journal of Surgery. 116-122.
  • 2016. Hepatoid adenocarcinoma of the stomach - Proper identification and treatment remain a challenge. 646-653.
  • 2016. Health-related quality of life, cachexia and overall survival after major upper abdominal surgery: A prospective cohort study. Scandinavian Journal of Surgery. 40-46.
  • 2016. Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies. Cancer Epidemiology. 39-46.
  • 2016. Epidemiology and classification of gastroenteropancreatic neuroendocrine neoplasms using current coding criteria. British Journal of Surgery. 226-232.
  • 2016. Epidemiology and Management of Rare Gastrointestinal Tumors: Lessons from gastroenteropancreatic neuroendocrine neoplasms gastrointestinal stromal tumors .
  • 2016. Clinical relevance of circulating KRAS mutated DNA in plasma from patients with advanced pancreatic cancer. Molecular Oncology. 635-643.
  • 2016. Clinical patterns of presentation and attenuated inflammatory response in octo- and nonagenarians with perforated gastroduodenal ulcers. Surgery. 341-349.
  • 2016. Assessment of clinically related outcomes and biomarker analysis for translational integration in colorectal cancer (ACROBATICC): Study protocol for a population-based, consecutive cohort of surgically treated colorectal cancers and resected colorectal liver metastasis. Journal of Translational Medicine. 9 pages.
  • 2015. Surgery for Gastrointestinal Stromal Tumors (GISTs) of the stomach and small bowel: Short- And long-term outcomes over three decades. World Journal of Surgery. 446-452.
  • 2015. Risk factors, complications and survival after upper abdominal surgery: A prospective cohort study. BMC Surgery. 8 pages.
  • 2015. Perforated peptic ulcer. The Lancet. 1288-1298.
  • 2015. Molecular subtypes in stage II-III colon cancer defined by genomic instability: Early recurrence-risk associated with a high copy-number variation and loss of RUNX3 and CDKN2A. PLOS ONE.
  • 2015. Long-term follow-up and survivorship after completing systematic surveillance in stage I–III colorectal cancer: who is still at risk? Journal of Gastrointestinal Cancer. 259-266.
  • 2015. Factors perceived to influence exercise adherence in women with breast cancer participating in an exercise programme during adjuvant chemotherapy: a focus group study. Journal of Clinical Nursing (JCN). 500-510.
  • 2015. Exercise: A Path to Wellness during Adjuvant Chemotherapy for Breast Cancer? Cancer Nursing. E13-E20.
  • 2015. Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer patients.
  • 2015. Clinical relevance of circulating tumor DNA in plasma from pancreatic cancer patients.
  • 2015. Adult pancreatic hemangioma in pregnancy - Concerns and considerations of a rare case. BMC Surgery. 1-6.
  • 2014. What is the best predictor of mortality in perforated peptic ulcer disease? A population-based, multivariable regression analysis including three clinical scoring systems. Journal of Gastrointestinal Surgery. 1261-1268.
  • 2014. Treatment of esophageal perforation in octogenarians: a multicenter study. Diseases of the esophagus. 715-718.
  • 2014. Strategies to improve the outcome of emergency surgery for perforated peptic ulcer. E51-E64.
  • 2014. Predicting outcomes in patients with perforated gastroduodenal ulcers: artificial neural network modelling indicates a highly complex disease. European Journal of Trauma and Emergency Surgery. 91-98.
  • 2014. Outcome of patients with esophageal perforations: a multicenter study. World Journal of Surgery. 902-909.
  • 2014. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av pasienter med pancreaskreft. .
  • 2014. Mean - and the reporting of continuous data. Digestive Surgery. 330.
  • 2014. KRAS mutation in patients undergoing hepatic resection for colorectal liver metastasis: A biomarker of cancer biology or a byproduct of patient selection? Cancer. 3862-3865.
  • 2014. Gastric diverticulum and halitosis - A case for surgery? International journal of surgery case reports. 431-433.
  • 2014. Effects of scheduled exercise on cancer-related fatigue in women with early breast cancer. Scientific World Journal. 9 pages.
  • 2013. Scoring systems for outcome prediction in patients with perforated peptic ulcer. 10.
  • 2013. Risk factors associated with poor lymph node harvest after colon cancer surgery in a national cohort. Colorectal Disease. E301-E308.
  • 2013. Qualitative and quantitative issues of lymph nodes as prognostic factor in colon cancer. 1-11.
  • 2013. Predicting exercise adherence in cancer patients and survivors: a systematic review and meta-analysis of motivational and behavioural factors. 4-21.
  • 2013. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. British Journal of Surgery. 373-380.
  • 2013. Patient-reported outcome measures after endoscopic retrograde cholangiopancreatography: a prospective, multicentre study. Scandinavian Journal of Gastroenterology. 868-876.
  • 2013. Influence of microsatellite instability and KRAS and BRAF mutations on lymph node harvest in stage I–III colon cancers. Molecular medicine (Cambridge, Mass. Print). 286-293.
  • 2013. Excess mortality after curative surgery for colorectal cancer changes over time and differs for patients with colon versus rectal cancer. Acta Oncologica. 933-940.
  • 2013. Epidemiology of perforated peptic ulcer: Age- and gender-adjusted analysis of incidence and mortality. World Journal of Gastroenterology (WJG). 347-354.
  • 2012. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib na < ve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome. Clinical and Translational Oncology. 619-629.
  • 2012. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients. Annals of Surgical Oncology. 3719-3726.
  • 2012. Esophageal perforation: clinical patterns and outcomes from a patient cohort of Western Norway. Digestive Surgery. 494-502.
  • 2012. Adherence to national guidelines for surveillance after curative resection of nonmetastatic colon and rectum cancer: a survey among Norwegian gastrointestinal surgeons. Colorectal Disease. 320-324.
  • 2011. Trends in diagnosis and surgical management of patients with perforated peptic ulcer. Journal of Gastrointestinal Surgery. 1329-1335.
  • 2011. Survival effect of implementing national treatment strategies for curatively resected colonic and rectal cancer. British Journal of Surgery. 716-723.
  • 2011. Prognostic role of carcinoembryonic antigen is influenced by microsatellite instability genotype and stage in locally advanced colorectal cancers. World Journal of Surgery. 888-894.
  • 2011. Palliativ gastroenterologisk kreftkirurgi. Kirurgen. 32-33.
  • 2011. Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials. Acta Oncologica. 1068-1074.
  • 2011. Esophageal perforation : diagnostic work-up and clinical decision-making in the first 24 hours. 7.
  • 2011. Epidemiology of gastrointestinal stromal tumours: single-institution experience and clinical presentation over three decades. Cancer Detection and Prevention. 515-520.
  • 2011. Diagnostic accuracy and receiver-operating characteristics curve analysis in surgical research and decision making. 27-34.
  • 2011. Contemporary use of endoscopic retrograde cholangiopancreatography (ERCP): A Norwegian prospective, multicenter study. Scandinavian Journal of Gastroenterology. 1144-1151.
  • 2011. A national audit of temporal trends in endoscopic retrograde cholangiopancreatography in Norway. Scandinavian Journal of Gastroenterology. 116-121.
  • 2010. Palliative surgical care. British Journal of Surgery. 970-971.
  • 2010. COMPARISON OF RELATIVE SURVIVAL IN RIGHT- AND LEFT SIDED ADENOCARCINOMA OF THE COLON IN A NATIONAL COHORT STUDY. Annals of Oncology. I58-I58.
  • 2010. Association With a High Number of Lymph Nodes and Microsatellite Instability in Colorectal Cancer. Archives of surgery (Chicago. 1960). 799-799.
  • 2009. Utilisation of specialist care in patients with incurable rectal cancer. A population-based study from Western Norway. Acta Oncologica. 377-384.
  • 2009. Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. Colorectal Disease. 838-844.
  • 2009. Microsatellite Instability and DNA Ploidy in Colorectal Cancer. Cancer. 271-282.
  • 2009. Lymph node harvest in colon cancer: influence of microsatellite instability and proximal tumor location. World Journal of Surgery. 2695-2703.
  • 2009. LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer. Cellular Oncology. 335-343.
  • 2009. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: Potential implications for the surgical oncologist. 31-50.
  • 2009. ERCP - Complications and patient satisfaction. Preliminary data from the Norwegian ERCP-registry in the"Gastronett" network. Scandinavian Journal of Gastroenterology. 37-37.
  • 2009. Diagnostic Accuracy of C-reactive Protein for Intraabdominal Infections After Colorectal Resections. Journal of Gastrointestinal Surgery. 1599-1606.
  • 2009. Co-expression of estrogen receptor agr and Apolipoprotein D in node positive operable breast cancer - possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients. Acta Oncologica. 514-521.
  • 2009. Apolipoprotein D predicts adverse outcome in women a parts per thousand yen70 years with operable breast cancer. Breast Cancer Research and Treatment. 519-528.
  • 2009. Acute appendicitis in the era of laparoscopy: The clinical management is influenced by age and gender. Scandinavian Journal of Gastroenterology. 35-36.
  • 2008. Surgery in Norway Beyond the Scalpel in the 21st Century. Archives of surgery (Chicago. 1960). 1011-1016.
  • 2008. Rectal cancer with macroscopic peritoneal involvement - clinical challenges and consequences. Colorectal Disease. 23 pages.
  • 2008. Prognostic Relevance of Androgen Receptor Detection in Operable Breast Cancer. Journal of Surgical Oncology. 551-558.
  • 2008. Palliative surgery for rectal cancer in a national cohort. Colorectal Disease. 336-343.
  • 2008. Kirurgisk behandling av levermetastaser fra kolorektal kreft. 50-53.
  • 2008. Comparison of Apolipoprotein D determination methods in breast cancer. Anticancer Research. 1151-1160.
  • 2008. Androgen receptor determination in breast cancer - A comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis. Applied immunohistochemistry & molecular morphology (Print). 362-370.
  • 2007. Type II error in a randomized controlled trial of appendectomy vs. antibiotic treatment of acute appendicitis. World Journal of Surgery. 871-872.
  • 2007. Tissue microarray and whole sections in small sized study populations for ER-alpha, PR, HER-2 and AR in operable breast cancer: correlation and relevance for prognostication. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 1314-1314.
  • 2007. Resuscitative emergency thoracotomy in a Scandinavian trauma hospital - is it justified? Injury. 34-42.
  • 2007. Prosthesis survival after total hip arthroplasty-does surgical approach matter? Analysis of 19,304 Charnley and 6,002 Exeter primary total hip arthroplasties reported to the Norwegian Arthroplasty Register. Acta Orthopaedica. 719-729.
  • 2007. Palliativ kirurgi innen kreftomsorg. Tidsskrift for Den norske legeforening. 2271-2273.
  • 2007. Oppfølging etter kurativ kirurgi for kolorektal kreft. 2959-2962.
  • 2007. Emerging concepts of apolipoprotein D with possible implications for breast cancer. 195-209.
  • 2007. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: A receiver operating characteristic curve analysis. Annals of Surgical Oncology. 417-423.
  • 2007. Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged > 55 years. Cellular Oncology. 25-35.
  • 2007. Clinical characteristics and outcomes in patients with advanced rectal cancer: A national prospective cohort study. Diseases of the Colon & Rectum. 285-291.
  • 2007. Bile duct cyst as precursor to biliary tract cancer. 1200-1211.
  • 2007. Androgen receptor determination in breast cancer: a comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis. Breast Cancer Research and Treatment. S216-S216.
  • 2007. ARHI (DIRAS3) and proliferation in lymph node negative breast cancer. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). 1318-1318.
  • 2006. Success predictors of adjuvant chemotherapy in node-negative breast cancer patients under 55 years. Cellular Oncology. 295-303.
  • 2006. Pyloroplasty for benign gastric outlet obstruction - indications and techniques. 11-16.
  • 2006. Gastroenterologisk kirurgi. Tidsskrift for Den norske legeforening. 91-91.
  • 2006. Effects and outcomes after palliative surgical treatment of malignant dysphagia. 376-381.
  • 2006. Benign peritoneal cystic mesothelioma. World Journal of Surgery. 560-566.
  • 2006. Axel H. Cappelen, MD (1858-1919): First suture of a myocardial laceration from a cardiac stab wound. Journal of Trauma. 653-654.
  • 2005. Validation of data in the Norwegian arthroplasty register and the Norwegian patient register. 5134 primary total hip arthroplasties and revisions operated at a single hospital between 1987 and 2003. Acta Orthopaedica. 823-828.
  • 2005. Validation of data in the Norwegian Arthroplasty Register and the Norwegian Patient Register - 5,134 primary total hip arthroplasties and revisions operated at a single hospital between 1987 and 2003. Acta Orthopaedica. 823-828.
  • 2005. Thyreoideakirurgi i Rogaland. Tidsskrift for Den norske legeforening. 23-26.
  • 2005. Systematic follow-up after curative surgery for colorectal cancer in Norway: A population-based audit of effectiveness, costs, and compliance. Journal of Gastrointestinal Surgery. 320-328.
  • 2005. Ethics of palliative surgery in patients with cancer. 802-809.
  • 2005. En 90 år gammel kvinne med akutt abdomen. Tidsskrift for Den norske legeforening. 888-890.
  • 2005. Acute pancreatitis in a young girl with the Netherton syndrome. Journal of Pediatric Surgery. 69-72.
  • 2004. Operable breast cancer patients with diagnostic delay - oncological and emotional characteristics. European Journal of Surgical Oncology. 721-727.
  • 2004. Bile duct cysts in adults. 1538-1548.
  • 2002. Tynntarmcarcinoid - kirurgi og strategi.
  • 2002. F. Hurler's syndrom. Tidlig klinisk mistanke. Tidsskrift for Den norske legeforening. 1552-55.
  • 2001. Stability in incidence of acute appendicitis. A population based longitudinal study. Digestive Surgery. 61-66.
  • 2001. Perforated and non-perforated appendicitis- one disease or two enteties ? The European Journal of Surgery. 525-30.
  • 2001. Når kreftsykdommen kommer i tillegg ... Tidsskrift for Den norske legeforening. 1046-51.
  • 2001. Diagnostic accuracy of inflamation markers in patients operated upon for suspected acute appendicitis: a receiver operating characteristics curve analysis. -96 pages.
  • 2000. The history is important in patients with suspected acute appendicitis. Digestive Surgery. 364-369.
  • 2000. Perforert og ikke-perforert appendisitt - to forskjellige sykdommer?
  • 2000. Perforert og ikke perforert akutt appendisitt - to forskjellige sykdommer?
  • 2000. Gastrointestinal carcinoid tumors - long term prognosis of surgically treated patients. World Journal of Surgery. 1431-36.
  • 2000. Binyrebark cancer. 3 pages.
  • 2000. "Incidentalom" i binyren. 2 pages.
  • 1997. The systemic and the mucosal immune response in young children after parenteral influenza vaccination.
  • 1997. Helicobacter pylori status after treatment for perforated gastroduodenal ulcer. A cross sectional study utilizing serology. Digestive Surgery. 366-370.
  • 1995. Mayo Clinic - et medisinsk Mekka i Midtvesten. Tidsskrift for Den norske legeforening. 2678-2679.
  • 1994. Primærbehandling av lokalavansert brystkreft med bruk av neoadjuvant kjemoterapi. Tidsskrift for Den norske legeforening. 668-670.
  • 1993. Spontaneous liver haematomas induced by anticoagulation therapy. A case report and review of the literature. Hepato-Gastroenterology. 402-406.
  • 1993. Ikke-traumatisk (spontan) miltruptur. Tidsskrift for Den norske legeforening. 1354-1355.
  • 1993. Diagnosis of brain metastases from a primary hemangiosarcoma of the spleen with magnetic resonance imaging (MRI). Cancer. 138-141.
  • 1992. Rapid C-reactive protein measurements in patients with acute appendicitis. Scandinavian Journal of Clinical and Laboratory Investigation. 585-589.
  • 1992. Primary morbidity and short-term results in a randomized trial of excision and primary suture versus excision and open packing in chronic pilonidal sinus disease. European Journal of Surgery. 351-355.
  • 1992. Pancreatic pseudocyst causing spontaneous gastric haemorrhage. European Journal of Surgery. 257-260.
  • 1992. Metastases to the small intestine from a subcutaneous lower extremity leiomyosarcoma. Acta Oncologica. 865-865.
  • 1992. Local resection of the papilla of Vater in ampullary cancer. Tidsskrift for Den norske legeforening. 2756-2758.
  • 1992. Androgen receptors in operable breast cancer:relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. European Journal of Surgical Oncology. 112-118.
  • 1992. Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. European Journal of Surgical Oncology. 112-118.
  • 1992. Akutt appendisitt. Preoperativ observasjonstid og diagnostisk treffsikkerhet. Tidsskrift for Den norske legeforening. 630-634.
  • 1991. Tumor cytosol proteins in operable breast cancer. Relevance for prognostication? (dr.med.).
  • 1991. Progesterone-binding cyst protein (PBCP=GCDFP-24) and steroid hormone receptors as markers of differentiation in breast cancer.Inverse relation of distribution in normal and malignant tissue of the same breast. Anticancer Research. 1323-1326.
  • 1991. Progesterone-binding cyst protein (PBCP) in operable breast cancer: Correlations with prognostic factors and predictive value for effect of adjuvan tamoxifen treatement. Anticancer Research. 601-606.
  • 1991. Progesteron-binding cyst protein (PBCP) in operable breast cancer: correlations with prognostic factors and predictive value for effect of adjuvant tamoxifen treatment. Anticancer Research. 601-606.
  • 1991. Cytosol protein content and prognosis in operable breast cancer. Correlations to steroid hormone and other prognostic factors. Breast Cancer Research and Treatment. 1-25.
  • 1991. Cystosol albumin content in operable breast cancer.Correlations to steroid hormone receptors, other prognostic factors and prognosis. Acta Oncologica. 797-802.

More information in national current research information system (CRIStin)